Author(s):
Sampoornam. W, Fathima Shamna PA, Kenza Sherin. P, Esther Vinod, Fathima Nasrin. M
Email(s):
sampoornamwebster@yahoo.co.in
DOI:
10.52711/2454-2660.2026.00060
Address:
Sampoornam. W1, Fathima Shamna PA2, Kenza Sherin. P3, Esther Vinod3, Fathima Nasrin. M3
1Principal, Bhavani College of Nursing – Erode, Tamil Nadu, India.
2BSc Nursing III-Year Students, Bhavani College of Nursing - Erode, Tamil Nadu, India.
3Bhavani College of Nursing - Erode, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2026
ABSTRACT:
Gaseous neurotransmitters, or gasotransmitters, represent a distinct class of endogenous signaling molecules characterized by membrane permeability, on-demand synthesis, and non-vesicular release. The principal gaseous neurotransmitters are nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S) which modulate synaptic plasticity, neurovascular coupling, oxidative balance, and neuroinflammatory responses. Increasing experimental and clinical evidence implicates dysregulation of these gaseous mediators in the pathophysiology of major psychiatric disorders, including major depressive disorder (MDD), schizophrenia, bipolar disorder, and anxiety-related conditions. This review synthesizes molecular, preclinical, and clinical findings linking altered gasotransmitter signaling with mental illness. The evidence suggests that gaseous neurotransmitters serve as both biomarkers and potential therapeutic targets in psychiatric disorders.
Cite this article:
Sampoornam. W, Fathima Shamna PA, Kenza Sherin. P, Esther Vinod, Fathima Nasrin. M. Gaseous Neurotransmitters and their Link to Mental Illness: Molecular Mechanisms, Clinical Correlates and Therapeutic Prospects. International Journal of Nursing Education and Research. 2026;14(4):289-0. doi: 10.52711/2454-2660.2026.00060
Cite(Electronic):
Sampoornam. W, Fathima Shamna PA, Kenza Sherin. P, Esther Vinod, Fathima Nasrin. M. Gaseous Neurotransmitters and their Link to Mental Illness: Molecular Mechanisms, Clinical Correlates and Therapeutic Prospects. International Journal of Nursing Education and Research. 2026;14(4):289-0. doi: 10.52711/2454-2660.2026.00060 Available on: https://ijneronline.com/AbstractView.aspx?PID=2026-14-4-4
REFERENCES:
1. Snyder, S. H., and Bredt, D. S. Nitric oxide as a neuronal messenger. Trends in Pharmacological Sciences. 1991; 12(4): 125–128.
2. Paul, B. D., and Snyder, S. H. Gasotransmitter signaling in psychiatric disorders. Biological Psychiatry. 2015; 78(7): 488–495.
3. Garthwaite, J. Concepts of neural nitric oxide-mediated transmission. European Journal of Neuroscience. 2008; 27(11): 2783–2802.
4. Maes, M., et al. Oxidative and nitrosative stress in depression. Progress in Neuropsychopharmacology and Biological Psychiatry. 2011; 35(3): 676–692.
5. Dhir, A., and Kulkarni, S. K. Nitric oxide and major depression. Nitric Oxide. 2011; 24(3): 125–131.
6. Wegiel, B., et al. Carbon monoxide in neuroprotection. Pharmacology and Therapeutics. 2013; 137(2): 133–152.
7. Kimura, H. Hydrogen sulfide as a neuromodulator. Molecular Neurobiology. 2002; 26(1): 13–19.
8. Peng, Y. J., et al. Hydrogen sulfide in neurological disorders. Neuroscience Bulletin. 2017; 33(2): 161–170.
9. Szabo, C. Gasotransmitters in disease. Nature Reviews Drug Discovery. 2007; 6(11): 917–935.